Skip to main content
A

APPLIED DNA SCIENCES INC — Investor Relations & Filings

Ticker · APDN ISIN · US03815U3005 LEI · 549300PCOT1RLQ23DL21 US Professional, scientific and technical activities
Filings indexed 1,014 across all filing types
Latest filing 2024-08-21 Regulatory Filings
Country US United States of America
Listing US APDN

About APPLIED DNA SCIENCES INC

https://adnas.com/

Applied DNA Sciences Inc. is a biotechnology company focused on the development and manufacture of DNA-based technologies for genetic medicine. The company's core expertise lies in polymerase chain reaction (PCR) and large-scale, cell-free enzymatic DNA synthesis. Its primary offering is lineaDNA™, a proprietary, linear form of DNA that serves as an alternative to plasmid DNA. This technology is designed for use in advanced therapeutic modalities, including the production of mRNA for vaccines and therapies, as well as for gene and cell therapies. Additionally, the company provides molecular and genomic diagnostic testing services through a clinical laboratory subsidiary.

Recent filings

Filing Released Lang Actions
DEFA14A
Regulatory Filings
2024-08-21 English
DEF 14A
Proxy Solicitation & Information Statement
2024-08-21 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-08-19 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-08-09 English
FORM 8-K
Regulatory Filings
2024-08-08 English
10-Q
Interim / Quarterly Report Q3 2024
2024-08-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.